On the other hand, ICC has lower mutation rates of TP53, SMAD4, APC, and ERBB2 and significantly less frequent mutations in KRAS, CDKN2A, and BRCA1 than in extrahepatic cholangiocarcinoma. The gene discussed is SMAD4; the disease is intrahepatic cholangiocarcinoma.